packagePasireotide

pasireotide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pasireotide, a somatostatin analogue, is used to treat Cushing's disease caused by excess pituitary ACTH secretion and acromegaly. It is an approved medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q3896970 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pasireotide
ATC codes:H01CB05
DrugBank:DB06663
PubChem CID:9941444
ChEBI:72312
Wikidata:Q3896970
formula:C58H66N10O9
molar mass:1047.23 g/mol (PubChem CID 9941444)
logP:4.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown